Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Nitisinone in Alkaptonuria
NCT00107783Phase 2Completed
- Sponsor
- National Human Genome Research Institute
- Start
- Jan 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitisinone in alkaptonuria (AKU), sponsored by National Human Genome Research Institute. Started Jan 2005; status: completed.
02
Drugs
nitisinone
03
Conditions
alkaptonuria (AKU)
Beyond the preview
Go deeper on NCT00107783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107783.